CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, View ORCID ProfileAdrián Montaño
doi: https://doi.org/10.1101/2021.07.13.21260256
Francisco José López-Jaime
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Sandra Martín-Téllez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Alberto Doblas-Márquez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Ignacio Márquez-Gómez
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
José María Reguera-Iglesias
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
Manuel Isidro Muñoz-Pérez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Ihosvany Fernández-Bello
‡Biopharm, Novo Nordisk, Madrid, Spain; (I.F.-B)
Adrián Montaño
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)

Article usage
Posted July 16, 2021.
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (579)
- Anesthesia (140)
- Cardiovascular Medicine (1947)
- Dermatology (184)
- Emergency Medicine (333)
- Epidemiology (11102)
- Gastroenterology (624)
- Genetic and Genomic Medicine (3170)
- Geriatric Medicine (309)
- Health Economics (561)
- Health Informatics (2042)
- Health Policy (863)
- Hematology (310)
- HIV/AIDS (682)
- Medical Education (317)
- Medical Ethics (92)
- Nephrology (334)
- Neurology (2986)
- Nursing (164)
- Nutrition (464)
- Oncology (1552)
- Ophthalmology (478)
- Orthopedics (185)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (913)
- Primary Care Research (355)
- Public and Global Health (5591)
- Radiology and Imaging (1094)
- Respiratory Medicine (760)
- Rheumatology (339)
- Sports Medicine (289)
- Surgery (343)
- Toxicology (48)
- Transplantation (159)
- Urology (132)